Insider Shareholders with Direct Ownership of Karyopharm Therapeutics Inc. (KPTI)
This section provides a comprehensive overview of the insiders with direct ownership of Karyopharm Therapeutics Inc. (KPTI). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Karyopharm Therapeutics Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Sharon Shacham
Chief Scientific Officer |
160,800 | 45,658 | 958,131 $7.21 Million | 11 |
Mar 29, 2022
Added 5.89%
|
|
Michael Kauffman
Director |
114,300 | 42,165 | 713,757 $5.37 Million | 10 |
Feb 28, 2022
Reduced 0.86%
|
|
Michael Mason
EVP, CFO & Treasurer |
450,401 | 83,797 | 391,054 $2.94 Million | 23 |
Sep 04, 2024
Reduced 1.77%
|
|
Ran Frenkel
EVP, Chief Dev. Officer |
105,588 | 11,516 | 168,290 $1.27 Million | 9 |
Feb 28, 2022
Reduced 0.98%
|
|
Lori Macomber
EVP, CFO & Treasurer |
160,000 | 0 | 160,000 $1.2 Million | 1 |
Jan 31, 2025
Added 50.0%
|
|
Jatin Shah
EVP, Chief Medical Officer |
58,176 | 7,198 | 129,450 $974,758 | 11 |
Feb 17, 2022
Reduced 1.0%
|
|
Stephen Mitchener
SVP, Chief Business Officer |
128,750 | 7,384 | 128,313 $966,196 | 7 |
Mar 01, 2023
Reduced 4.72%
|
|
Richard A. Paulson
President and CEO |
1,418,750 | 290,286 | 82,984 $624,869 | 44 |
Mar 04, 2025
Reduced 12.35%
|
|
Tanya Lewis
EVP, Chief Reg. Affairs |
28,428 | 2,272 | 45,401 $341,869 | 5 |
Feb 25, 2021
Added 32.65%
|
| 45,140 | 0 | 45,140 $339,904 | 2 |
Sep 12, 2023
Added 47.68%
|
|
|
Sohanya Roshan Cheng
EVP & Chief Commercial Officer |
444,625 | 57,794 | 34,314 $258,384 | 15 |
Mar 04, 2025
Reduced 9.12%
|
|
Reshma Rangwala
EVP & Chief Medical Officer |
388,125 | 38,782 | 29,272 $220,418 | 10 |
Mar 04, 2025
Reduced 10.92%
|
|
Stuart Poulton
EVP, Chief Development Officer |
306,121 | 49,372 | 27,414 $206,427 | 12 |
Mar 04, 2025
Reduced 11.46%
|
|
John Demaree
Chief Commercial Officer |
15,849 | 0 | 23,995 $180,682 | 1 |
Feb 25, 2021
Added 39.78%
|
|
Michael Mano
SVP, General Counsel&Secretary |
314,750 | 38,079 | 21,047 $158,483 | 12 |
Mar 04, 2025
Reduced 11.72%
|
| 7,576 | 0 | 13,606 $102,453 | 1 |
Aug 11, 2022
Added 35.77%
|
|
|
Kristin Abate
Chief Accounting Officer |
933 | 571 | 9,713 $73,138 | 2 |
Mar 04, 2025
Reduced 5.55%
|
|
Christopher Brett Primiano
EVP, CBO, GC & Secretary |
176,332 | 177,104 | 4,523 $34,058 | 5 |
Dec 01, 2020
Reduced 92.87%
|
| 25,000 | 25,000 | 0 $0 | 4 |
Dec 18, 2020
Reduced 100.0%
|